Gene therapy and Biomarker for Diabetes

Biomarkers are useful tools for research into type 1 diabetes (T1D) for a number of purposes, including elucidation of disease pathogenesis, risk prediction, and therapeutic monitoring. Susceptibility genes and islet autoantibodies are currently the most useful biomarkers for T1D risk prediction, progress, opportunities, challenges, and future directions in the development of T1D biomarkers.

 

    Related Conference of Gene therapy and Biomarker for Diabetes

    April 04-05, 2024

    27th Euro-Global Summit on Food and Beverages

    Madrid, Spain
    April 11-12, 2024

    18th International Conference on Food Microbiology

    Amsterdam, Netherlands
    April 11-12, 2024

    2nd International conference on Food and Agri Tech

    Amsterdam, Netherlands
    April 17-18, 2024

    7th European Food Science Congress

    Amsterdam, Netherlands
    April 18-19, 2024

    33rd World Conference on Food and Beverages

    Dubai, UAE
    September 09-10, 2024

    5th International Conference on Food and Nutrition

    Paris, France
    October 21-22, 2024

    28th International Conference on Food and Nutrition

    Paris, France
    November 27-28, 2024

    32nd International Conference on Food & Nutrition

    Paris, France

    Gene therapy and Biomarker for Diabetes Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in